Relating to disclosures of preauthorization requirements and explanations of benefits for medical and health care services and supplies covered by health maintenance organizations and preferred provider benefit plans; imposing administrative penalties.
Relating to the scheduling of certain controlled substances in response to certain actions by the United States Food and Drug Administration with respect to those substances.